A new study published in PubMed explores the clinical and genotypic spectrum of propionic acidemia in Mexico, providing valuable insights into the disease's manifestations and genetic variations. This research contributes to the understanding of propionic acidemia, which can inform future treatment approaches.

A new study explores the use of antisense oligonucleotides to skip a pseudoexon in the PCCA gene, offering potential versatility in treating propionic acidemia. This research could pave the way for innovative therapeutic strategies for this rare metabolic disorder.

A recent natural history study characterizes clinical events and assesses biomarkers in propionic acidemia. This research provides valuable insights into the disease's progression and potential biomarkers for monitoring.